Moteur de recherche d’entreprises européennes

Financement de l’UE (7 496 896 €) : La biodiversité marine en tant que ressource durable de microbes suppresseurs de maladies et de bioprotecteurs pour l’aquaculture et les maladies des cultures Hor01/05/2021 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

La biodiversité marine en tant que ressource durable de microbes suppresseurs de maladies et de bioprotecteurs pour l’aquaculture et les maladies des cultures

MARBLES will use a novel and systematic approach to access and exploit marine microbial biodiversity for sustainable bioprospecting to discover microbial consortia and bioactive molecules for application in aqua- and agriculture and in the clinic. MARBLES' ecology-based bioprospecting strategy will focuses on unique host-microbe interactions in marine environments, including marine sponges, microalgae and fish, which rely on their microbiomes and microbial natural products for disease resistance. Partners’ existing microbial collections and new ones generated during MARBLES will be harnessed for the discovery of novel natural products and synthetic microbial communities. For this, MARBLES will use a systems-wide genomics approach to uncover the bioactive agents in disease-suppressive microbiomes. Also, MARBLES will explore host- and microbe-derived chemicals that elicit production of bioactive compounds, as elicitors to revitalise drug screening. The deliverables will be microbes and consortia and bioactive natural products, their derivatives and elicitors, which can be harnessed to fight infectious diseases in the agrochemical and aquaculture industries and in healthcare. Besides highly innovative, the approaches will be cost-effective and will offer advantages from both environmental and health perspectives in comparison to existing alternatives. The sustainable production of bioprotectants will increase the effectiveness of fish production - reducing the pressure on harvesting wild fish - and aid the transition of the crop agriculture sector towards bio-based and circular solutions. MARBLES will work closely together with a panel of SMEs and large companies from the EU aquaculture, crop protection biotechnology and health sectors. MARBLES fully complies with the Nagoya and Cartagena Protocols, and aims to make major contributions to the UN sustainable development goals, SDG 2, 3, 12, 13 and 14, as well as to current UN processes (BBNJ, DSI, SynBio)


ABS-International 489 375 €
Danmarks Tekniske Universitet 713 125 €
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH 452 615 €
Erinn Innovation Ltd. 469 680 €
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM (e.U.-OPENSCREEN ERIC) 76 250 €
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. 285 750 €
Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia 685 619 €
Naicons Srl 433 929 €
Sintef AS 536 375 €
STICHTING NATURALIS BIODIVERSITY CENTER 513 170 €
The University Court of the University of Aberdeen 638 089 €
UNIVERSITEIT LEIDEN 1 098 620 €
University College Cork - National University of Ireland, Cork 606 505 €
WAGENINGEN UNIVERSITY 497 795 €

https://cordis.europa.eu/project/id/101000392

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.

Creative Commons License Les visualisations de "ABS-International - Financement de l’UE (7 496 896 €) : La biodiversité marine en tant que ressource durable de microbes suppresseurs de maladies et de bioprotecteurs pour l’aquaculture et les maladies des cultures" sont mis à disposition par North Data et peuvent être réutilisées selon les termes de la licence Creative Commons CC-BY.